A major study published in The Lancet analyzing 2.5 million U.S. women found that those with polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS) have four times the risk of cardiovascular disease, including heart attacks and strokes, compared to women without the condition.
Defense Secretary Pete Hegseth announced mandatory annual testosterone deficiency screenings for US service members 30 years and older as part of their physical exams, an initiative he said was aimed at improving warfighter readiness.
Healthcare providers and patients across the United States are reporting intermittent shortages of oral progesterone, a hormone widely used in fertility and menopause treatments. The supply strain reflects growing demand for hormone replacement therapy.
A large UK trial published in the New England Journal of Medicine found that women's hormone replacement therapy patches can treat prostate cancer just as effectively as standard hormone injections but with fewer severe side effects.
Cornell researchers have taken a significant step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, with proof-of-concept results representing progress toward what's considered the 'holy grail' of male contraception.
